Keywords
- Chronic Myeloid Leukemia
- International HapMap Consortium
- Breast Cancer Susceptibility Locus
- Comparative Genomic Hybridiza
- Autoantibody Signature
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Amundadottir, L., Sulem, P., Gudmundsson, J., et al. (2006). A common variant associated with prostate cancer in european and african populations. Nature Genetics, 38(6):652–658.
Benjamini, Y. and Hochberg, Y. (1995). Controlling for false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B, 57:289–300.
Druker, B. J., Guilhot, F., O’Brien, S. G., et al. (2006). Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. New England Journal of Medicine, 355(23):2408–2417.
Easton, D., Pooley, K., Dunning, A., et al. (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447(7148): 1087–1093.
Efron, B. (2004). Large-scale simultaneous hypothesis testing: The choice of a null hypothesis. Journal of the American Statistical Association, 99:96–104.
Faca, V., Coram, M., Phanstiel, D., et al. (2006). Quantitative analysis of acrylamide labeled serum proteins by lc-ms/ms. Journal of Proteome Research, 5(8):2009–2018.
Felsenstein, J. (2007). Theoretical Evolutionary Genetics. University of Washington/ASUW Publishing, Seattle, WA.
Freedman, M. L., Haiman, C. A., Patterson, N., et al. (2006). Admixture mapping identifies 8q24 as a prostate cancer risk locus in african-american men. Proceedings of the National Academy of Sciences, 103(38):14068–14073.
Golub, T. R., Slonim, D. K., Tamayo, P., et al. (1999). Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science, 286(5439):531–537.
Hinds, D. A., Stuve, L. L., Nilsen, G. B., et al. (2005). Whole-genome patterns of common DNA variation in three human populations. Science, 307(5712):1072–1079.
Hunter, D. J., Kraft, P., Jacobs, K. B., et al. (2007). A genome-wide association study identifies alleles in fgfr2 associated with risk of sporadic postmenopausal breast cancer. Nature Genetics, 39(6):870–874.
Khatri, P. and Draghici, S. (2005). Ontological analysis of gene expression data: current tools, limitations, and open problems. Bioinformatics, 18:3587–3595.
Ott, J. (1991). Analysis of Human Genetic Linkage. Johns Hopkins University Press, Baltimore, MD.
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., et al. (2005). Trastuzumab after adjuvant chemotherapy in her2-positive breast cancer. New England Journal of Medicine, 353(16):1659–1672.
Prentice, R. and Qi, L. (2006). Aspects of the design and analysis of high-dimensional snp studies for disease risk estimation. Biostatistics, 7:339–354.
Rouzier, R., Perou, C. M., Symmans, W. F., et al. (2005). Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clinical Cancer Research, 11(16):5678–5685.
Ruczinski, I., Kooperberg, C., and LeBlanc, M. (2003). Logic regression. Journal of Computational and Graphical Statististics, 12:475–511.
Samani, N. J., Erdmann, J., Hall, A. S., et al. (2007). Genomewide association analysis of coronary artery disease. New England Journal of Medicine, 357(5):443–453.
Shurubor, Y., Matson, W., Martin, R., et al. (2005). Relative contribution of specific sources of systematic errors and analytic imprecision to metabolite analysis by hplc-ecd. Metabolomics, 1:159–168.
The International HapMap Consortium (2003). The international hapmap project. Nature, 426(6968):789–796.
The Women's Health Initiative Steering Committee (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The women's health initiative randomized controlled trial. JAMA, 291(14):1701–1712.
Thomas, D. (2004). Statistical Methods in Genetic Epidemiology. Oxford University Press, London.
Tibshirani, R. (1996). Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society B, 58:267–288.
Wang, X., Yu, J., Sreekumar, A., et al. (2005). Autoantibody signatures in prostate cancer. New England Journal of Medicine, 353(12):1224–1235.
Writing Group for the Women's Health Initiative Investigators (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial. Journal of the American Medical Association, 288(3):321–333.
Yeager, M., N., O., Hayes, R. B., et al. (2007). Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nature Genetics, 39(5):645–649.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Prentice, R.L. (2009). On the Role and Potential of High-Dimensional Biologic Data in Cancer Research. In: Li, X., Xu, R. (eds) High-Dimensional Data Analysis in Cancer Research. Applied Bioinformatics and Biostatistics in Cancer Research. Springer, New York, NY. https://doi.org/10.1007/978-0-387-69765-9_1
Download citation
DOI: https://doi.org/10.1007/978-0-387-69765-9_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-69763-5
Online ISBN: 978-0-387-69765-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)